ArticleBiological psychiatry global open sciencePublished
Efficacy and Safety of the Selective, Brain-Penetrant P2X7 Receptor Antagonist JNJ-55308942 (Zanvipixant) in Bipolar Depression: A Phase 2a Study
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Mercer County
Publication record
- Type
- Article
- Venue
- Biological psychiatry global open science
- Published
- Topic
- Clinical care
- Subject terms
- Genetic markers; Bipolar disorder; Neuroimmunology; Randomized Clinical Trial; Patient-reported Outcomes; Montgomery–åsberg Depression Rating Scale
- PubMed ID
- 42181295
- PubMed Central ID
- PMC13196505
- Open access
- Yes, open
- Added to directory
- Source checked